Conditions

Impaired insulin response in midlife is associated with an increased risk of developing Alzheimer’s disease (AD) up to 35 years later, Swedish researchers report.

Following a healthy diet or taking metformin may help to delay or prevent diabetes in women with a history of gestational diabetes mellitus (GDM) and impaired glucose tolerance, according to the results of a randomized controlled clinical trial.

In a postmortem study of patients who had Alzheimer’s disease, those who also had diabetes and were treated with insulin and oral hypoglycemic drugs had lower densities of neural plaques in the brain, a hallmark of this dementia, than did other diabetics or those without diabetes, new research shows.

Dialysis patients diagnosed with depression are nearly twice as likely to be hospitalized or die within a year than those who are not depressed, a UT Southwestern Medical Center researcher has found.

Diabetics who take insulin plus a sulfonylurea diabetes pill have a lower risk of developing Alzheimer’s disease than diabetics who take insulin alone, researchers said.

Fenofibrate in combination with coenzyme Q10 (CoQ) appears to have a number of beneficial effects in type 2 diabetic subjects with mild left ventricular (LV) diastolic dysfunction, researchers report.

Young women with gestational diabetes mellitus (GDM) are at significantly increased risk of developing cardiovascular disease, compared to women without GDM, according to a new study.

A drug that fights aging and halts the onset of diabetes, cancer and heart disease, may hit market shelves in another five years, claim researchers.

Pregnant women with gestational impaired glucose tolerance (GIGT) may exhibit the same adverse outcomes as do women with gestational diabetes mellitus, according to the results of a new study

People with impaired glucose tolerance were 81% less likely to develop type 2 diabetes over a 3-year period if treated with pioglitazone, according to the findings of an industry-sponsored randomized, double-blind, placebo-controlled study of 602 patients.